MediPharm Labs Corp. (OTCMKTS:MEDIF – Get Free Report) was the target of a significant decline in short interest in August. As of August 31st, there was short interest totaling 997 shares, a decline of 94.3% from the August 15th total of 17,636 shares. Based on an average daily volume of 108,289 shares, the short-interest ratio is presently 0.0 days.
MediPharm Labs Stock Down 2.6%
Shares of MediPharm Labs stock traded down $0.00 on Thursday, hitting $0.05. The stock had a trading volume of 316 shares, compared to its average volume of 78,342. MediPharm Labs has a 52-week low of $0.04 and a 52-week high of $0.08. The company’s 50 day moving average price is $0.05 and its 200 day moving average price is $0.05.
MediPharm Labs Company Profile
MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.
The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products.
Featured Stories
- Five stocks we like better than MediPharm Labs
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
